G
Gain Therapeutics, Inc. (GANX)
NGM – Real Time Price. Currency in USD
1.80
-0.02 (-1.10%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
1.80
-0.02 (-1.10%)
At close: May 12, 2026, 4:00 PM EDT
Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia. The company’s drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease. Its lead drug candidate is GT-02287, which is currently in a Phase 1b study for the treatment of Parkinson’s disease with or without a GBA1 mutation. The company has various small molecule drug candidates, which are in the discovery, research, and preclinical stages for the treatment of dementia with Lewy bodies, Alzheimer's disease, and Gaucher’s disease, lysosomal storage disorders, metabolic disorders, and solid tumors. Gain Therapeutics, Inc. was founded in 2017 and is based in Bethesda, Maryland.
| Name | Position |
|---|---|
| Dr. Joanne Taylor Ph.D. | Senior Vice President of Research |
| Dr. Jonas Hannestad M.D., Ph.D. | Chief Medical Officer |
| Dr. Khalid Islam Ph.D. | Chairman & Founder |
| Dr. Terenzio Ignoni Pharm.D. | Senior Vice President of Technical Operations |
| Mr. Gene Mack M.B.A. | President, CEO & Director |
| Mr. Gianluca Fuggetta | Senior VP of Finance & Principal Financial Officer |
| Date | Type | Document |
|---|---|---|
| 2026-04-28 | DEFA14A | ganx-20260428xdefa14a.htm |
| 2026-04-28 | DEF 14A | ganx-20260624xdef14a.htm |
| 2026-03-26 | 8-K | ganx-20260326x8k.htm |
| 2026-03-26 | 10-K | ganx-20251231x10k.htm |
| 2026-03-18 | 8-K | tm269191d1_8k.htm |
| 2026-02-03 | 8-K | tm265021d1_8k.htm |
| 2025-12-18 | 8-K | tm2533810d1_8k.htm |
| 2025-12-03 | S-8 | tm2532477d1_s8.htm |
| 2025-11-28 | 8-K | tm2530369d4_8k.htm |
| 2025-11-12 | 8-K | ganx-20251112x8k.htm |